Abstract
Natural polymers have proved to be useful in versatile applications, including controlled drug delivery, gene delivery, regenerative medicine, and other biomedical applications. These polymers are obtained primarily from plants, animals, and microbial sources which are again classified based on their chemistry into polysaccharide, protein, polyester, polyamide-based polymers. The in-depth surveys of these polymers reveals their malleable nature to be modified for various applications. Also, their responsive chemical linkages provide ease of biodegradability, which in turn makes them biocompatible. Their desirable features of ample abundance, biocompatibility, and biodegradability make them potential material for various uses. The eco-friendly profile of these polymers makes researchers inclined towards alluring natural polymers. This chapter describes natural polymers obtained from different sources and provides insights on the origin, chemistry, key features, applications, and marketed products of natural polymers that are being explored as adaptable materials in multifaceted areas.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CDs:
-
Cyclodextrin
- HPMC:
-
Hydroxy propyl methyl cellulose
- MCC:
-
Micro crystalline cellulose
- GFR:
-
Glomerular filtration rate
- DE:
-
Degree of esterification
- SPIONs:
-
Super paramagnetic iron oxide nanoparticles
- CaPG:
-
Calcium pectinate gel
- KGM:
-
Konjac glucomannan
- BSA:
-
Bovine serum albumin
- AG:
-
Arabinogalactan
- AGP:
-
Arabinogalactan protein
- GAG:
-
Glycosaminoglycan
- HA:
-
Hyaluronic acid
- CS:
-
Chondroitin sulphate
- ECM:
-
Extracellular matrix
- HAS:
-
Hyaluronan synthases
- IdoA:
-
l-iduronic acid
- TC:
-
Tropocollagen
- FACITs:
-
Fibril associated collagens with interrupted triple helices
- MACITs:
-
Membrane associated collagens with interrupted triple helices
- MULTIPLEXINS:
-
Multiple triple helix domains and interruptions
- HSA:
-
Human serum albumin
- EPR:
-
Enhanced permeability and retention effect
- BMMNCs:
-
Bone marrow mono-nuclear cells
- ADSCs:
-
Adipose derived stem cells
- bFGF:
-
Basic fibroblast growth factor
- FH:
-
Fibrin-H-chain
- FL:
-
Fibrin-L-chain
- RSF:
-
Regenerated silk fibroin
- SFCS:
-
Silk fibroin chitosan scaffold
- GalCS:
-
Galactosylated chitosan scaffold
- PHA:
-
Poly hydroxy alkanoate
- PHB:
-
Poly hydroxy butyrate
- PHBV:
-
Poly (hydroxybutyrate-co-hydroxyvalerate)
- PHBH:
-
Poly (hydroxybutyrate-co-hydroxyhexanoate)
- PHBO:
-
Poly (hydroxybutyrate-co-hydroxyoctanoate)
- sCL:
-
Short chain length
- mCL:
-
Medium chain length
References
Laza-Knoerr, A., Gref, R., Couvreur, P.: Cyclodextrins for drug delivery. J. Drug Target. 18(9), 645–656 (2010)
Challa, R., Ahuja, A., Ali, J., Khar, R.: Cyclodextrins in drug delivery: an updated review. Aaps Pharmscitech 6(2), E329–E357 (2005)
Muntimadugu, E., Ickowicz, D.E., Domb, A.J., Khan, W.: Polysaccharide biomaterials. Isr. J. Chem. 53(9–10), 787–794 (2013)
Vyas, A., Saraf, S., Saraf, S.: Cyclodextrin based novel drug delivery systems. J. Incl. Phenom. Macrocycl. Chem. 62(1–2), 23–42 (2008)
Loftsson, T., Jarho, P., Masson, M., Järvinen, T.: Cyclodextrins in drug delivery. Expert Opin. Drug Deliv. 2(2), 335–351 (2005)
Khan, W., Muthupandian, S., Domb, A.J.: Cationic polymers for the delivery of therapeutic nucleotides. Nanotechnology for the Delivery of Therapeutic Nucleic Acids. Pan Stanford Publishing, Singapore (2013)
Swami, R., Singh, I., Khan, W., Ramakrishna, S.: Diseases originate and terminate by genes: unraveling nonviral gene delivery. Drug Deliv. Transl. Res. 3(6), 593–610 (2013)
Khan, W., Hosseinkhani, H., Ickowicz, D., Hong, P.D., Yu, D.S., Domb, A.J.: Polysaccharide gene transfection agents. Acta Biomater. 8(12), 4224–4232 (2012). S1742-7061(12)00459-X[pii]/j.actbio.2012.09.022
Merkus, F., Verhoef, J., Marttin, E., Romeijn, S., Van der Kuy, P., Hermens, W., Schipper, N.: Cyclodextrins in nasal drug delivery. Adv. Drug Deliv. Rev. 36(1), 41–57 (1999)
Loftsson, T., Brewster, M.E., Másson, M.: Role of cyclodextrins in improving oral drug delivery. Am. J. Drug Deliv. 2(4), 261–275 (2004)
Redenti, E., Pietra, C., Gerloczy, A., Szente, L.: Cyclodextrins in oligonucleotide delivery. Adv. Drug Deliv. Rev. 53(2), 235–244 (2001)
Neill, M.J., Mahony, A.M., Byrne, C., Darcy, R., Driscoll, C.M.: Gastrointestinal gene delivery by Cyclodextrins—In vitro quantification of extracellular barriers. Int. J. Pharm. 456(2), 390–399 (2013)
Lai, W.-F.: Cyclodextrins in non-viral gene delivery. Biomaterials 35(1), 401–411 (2014)
Tan, H., Qin, F., Chen, D., Han, S., Lu, W., Yao, X.: Study of glycol chitosan-carboxymethyl β-cyclodextrins as anticancer drugs carrier. Carbohydr. Polym. 93(2), 679–685 (2013)
Matsuda, H., Arima, H.: Cyclodextrins in transdermal and rectal delivery. Adv. Drug Deliv. Rev. 36(1), 81–99 (1999)
Loftssona, T., Jarvinen, T.: Cyclodextrins in ophthalmic drug delivery. Adv. Drug Deliv. Rev. 36(1), 59–79 (1999)
Bibby, D.C., Davies, N.M., Tucker, I.G.: Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int. J. Pharm. 197(1), 1–11 (2000)
Nishiyama, Y., Langan, P., Chanzy, H.: Crystal structure and hydrogen-bonding system in cellulose Iβ from synchrotron X-ray and neutron fiber diffraction. J. Am. Chem. Soc. 124(31), 9074–9082 (2002)
Aguilera J.M., Stanley D.W.: Microstructural principles of food processing and engineering, pp. 166–168. Springer, New York (1999)
Cosgrove, D.J.: Growth of the plant cell wall. Nat. Rev. Mol. Cell Biol. 6(11), 850–861 (2005)
Hon, D.N.S.: Cellulose and its derivatives: structures, reactions, and medical uses. In: Severian D. (ed.) Polysaccharides in Medicinal Applications, pp. 87–105. Marcel Dekker, New York (1996)
Conti, S., Maggi, L., Segale, L., Ochoa Machiste, E., Conte, U., Grenier, P., Vergnault, G.: Matrices containing NaCMC and HPMC: 1. Dissolution performance characterization. Int. J. Pharm. 333(1), 136–142 (2007)
Jamzad, S., Fassihi, R.: Development of a controlled release low dose class II drug-Glipizide. Int. J. Pharm. 312(1), 24–32 (2006)
Scheller, H.V., Ulvskov, P.: Hemicelluloses. Plant Biol. 61(1), 263–289 (2010)
Lerouxel, O., Cavalier, D.M., Liepman, A.H., Keegstra, K.: Biosynthesis of plant cell wall polysaccharides—a complex process. Curr. Opin. Plant Biol. 9(6), 621–630 (2006)
Elvira, C., Mano, J., San Roman, J., Reis, R.: Starch-based biodegradable hydrogels with potential biomedical applications as drug delivery systems. Biomaterials 23(9), 1955–1966 (2002)
Malafaya, P., Elvira, C., Gallardo, A., San Roman, J., Reis, R.: Porous starch-based drug delivery systems processed by a microwave route. J. Biomater. Sci. Polym. Ed. 12(11), 1227–1241 (2001)
Santander-Ortega, M., Stauner, T., Loretz, B., Ortega-Vinuesa, J., Bastos-González, D., Wenz, G., Schaefer, U., Lehr, C.: Nanoparticles made from novel starch derivatives for transdermal drug delivery. J. Controlled Release 141(1), 85–92 (2010)
Vilivalam, V.D., Illum, L., Iqbal, K.: Starch capsules: an alternative system for oral drug delivery. Pharm. Sci. Technol. Today 3(2), 64–69 (2000)
Izawa, K., Akiyama, K., Abe, H., Togashi, Y., Hasegawa, T.: Inulin-based glycopolymer: its preparation, lectin-affinity and gellation property. Bioorg. Med. Chem. 21(11), 2895–2902 (2013)
Akhgari, A., Farahmand, F., Afrasiabi Garekani, H., Sadeghi, F., Vandamme, T.F.: Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery. Eur. J. Pharm. Sci. 28(4), 307–314 (2006)
Maris, B., Verheyden, L., Van Reeth, K., Samyn, C., Augustijns, P., Kinget, R., Van den Mooter, G.: Synthesis and characterisation of inulin-azo hydrogels designed for colon targeting. Int. J. Pharm. 213(1), 143–152 (2001)
Pitarresi, G., Giacomazza, D., Triolo, D., Giammona, G., San Biagio, P.L.: Rheological characterization and release properties of inulin-based hydrogels. Carbohydr. Polym. 88(3), 1033–1040 (2012)
Mohnen, D.: Pectin structure and biosynthesis. Curr. Opin. Plant Biol. 11(3), 266–277 (2008)
Liu, L., Fishman, M.L., Kost, J., Hicks, K.B.: Pectin-based systems for colon-specific drug delivery via oral route. Biomaterials 24(19), 3333–3343 (2003)
Jung, J., Arnold, R.D., Wicker, L.: Pectin and charge modified pectin hydrogel beads as a colon-targeted drug delivery carrier. Colloids Surf. B Biointerfaces 104, 116–121 (2013)
Munjeri, O., Collett, J., Fell, J.: Hydrogel beads based on amidated pectins for colon-specific drug delivery: the role of chitosan in modifying drug release. J. Controlled Release 46(3), 273–278 (1997)
Fernandez-Hervas, M., Fell, J.: Pectin/chitosan mixtures as coatings for colon-specific drug delivery: an in vitro evaluation. Int. J. Pharm. 169(1), 115–119 (1998)
Itoh, K., Yahaba, M., Takahashi, A., Tsuruya, R., Miyazaki, S., Dairaku, M., Togashi, M., Mikami, R., Attwood, D.: In situ gelling xyloglucan/pectin formulations for oral sustained drug delivery. Int. J. Pharm. 356(1), 95–101 (2008)
Dutta, R.K., Sahu, S.: Development of oxaliplatin encapsulated in magnetic nanocarriers of pectin as a potential targeted drug delivery for cancer therapy. Results Pharma Sci. 2, 38–45 (2012)
Smistad, G., Boyum, S., Alund, S.J., Samuelsen, A.B.C., Hiorth, M.: The potential of pectin as a stabilizer for liposomal drug delivery systems. Carbohydr. Polym. 90(3), 1337–1344 (2012)
Kumar, P., Ramya, C., Jayakumar, R., Lakshmanan, V.-K.: Drug delivery and tissue engineering applications of biocompatible pectin-chitin/nano CaCO3 composite scaffolds. Colloids Surf. B Biointerfaces 106, 109–116 (2013)
Luppi, B., Bigucci, F., Abruzzo, A., Corace, G., Cerchiara, T., Zecchi, V.: Freeze-dried chitosan/pectin nasal inserts for antipsychotic drug delivery. Eur. J. Pharm. Biopharm. 75(3), 381–387 (2010)
Katsuraya, K., Okuyama, K., Hatanaka, K., Oshima, R., Sato, T., Matsuzaki, K.: Constitution of konjac glucomannan: chemical analysis and 13C NMR spectroscopy. Carbohydr. Polym. 53(2), 183–189 (2003)
Fan, J., Wang, K., Liu, M., He, Z.: In vitro evaluations of konjac glucomannan and xanthan gum mixture as the sustained release material of matrix tablet. Carbohydr. Polym. 73(2), 241–247 (2008)
Alvarez-Mancenido, F., Landin, M., Lacik, I., Martinez-Pacheco, R.: Konjac glucomannan and konjac glucomannan/xanthan gum mixtures as excipients for controlled drug delivery systems. Diffusion of small drugs. Int. J. Pharm. 349(1), 11–18 (2008)
Wen, X., Wang, T., Wang, Z., Li, L., Zhao, C.: Preparation of konjac glucomannan hydrogels as DNA-controlled release matrix. Int. J. Biol. Macromol. 42(3), 256–263 (2008)
Prabaharan, M.: Prospective of guar gum and its derivatives as controlled drug delivery systems. Int. J. Biol. Macromol. 49(2), 117–124 (2011)
Shukla, R.K., Tiwari, A.: Carbohydrate polymers: Applications and recent advances in delivering drugs to the colon. Carbohydr. Polym. 88(2), 399–416 (2012)
Krishnaiah, Y., Satyanarayana, S., Rama Prasad, Y., Narasimha Rao, S.: Evaluation of guar gum as a compression coat for drug targeting to colon. Int. J. Pharm. 171(2), 137–146 (1998)
Prasad, Y., Krishnaiah, Y., Satyanarayana, S.: In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. J. Controlled Release 51(2), 281–287 (1998)
Li, X., Wu, W., Wang, J., Duan, Y.: The swelling behavior and network parameters of guar gum/poly (acrylic acid) semi-interpenetrating polymer network hydrogels. Carbohydr. Polym. 66(4), 473–479 (2006)
George, M., Abraham, T.: pH sensitive alginate-guar gum hydrogel for the controlled delivery of protein drugs. Int. J. Pharm. 335(1), 123–129 (2007)
Krishnaiah, Y., Karthikeyan, R., Gouri Sankar, V., Satyanarayana, V.: Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride. J. Controlled Release 81(1), 45–56 (2002)
Krishnaiah, Y., Karthikeyan, R., Satyanarayana, V.: A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate. Int. J. Pharm. 241(2), 353–366 (2002)
Li, X., Wu, W., Liu, W.: Synthesis and properties of thermo-responsive guar gum/poly (N-isopropylacrylamide) interpenetrating polymer network hydrogels. Carbohydr. Polym. 71(3), 394–402 (2008)
Thakur, S., Chauhan, G.S., Ahn, J.-H.: Synthesis of acryloyl guar gum and its hydrogel materials for use in the slow release of l-DOPA and l-tyrosine. Carbohydr. Polym. 76(4), 513–520 (2009)
Ponder, G.R.: Arabinogalactan from Western larch. Part IV. Polymeric products of partial acid hydrolysis. Carbohydr. Polym. 36(1), 1–14 (1998)
Showalter, A.: Arabinogalactan-proteins: structure, expression and function. Cell. Mol. Life Sci. 58(10), 1399–1417 (2001)
Parveen, S., Gupta, A.D., Prasad, R.: Arabinogalactan protein from Arachis hypogaea: Role as carrier in drug-formulations. Int. J. Pharm. 333(1), 79–86 (2007)
Prescott, J.H., Enriquez, P., Jung, C., Menz, E., Groman, E.V.: Larch arabinogalactan for hepatic drug delivery: isolation and characterization of a 9 kDa arabinogalactan fragment. Carbohydr. Res. 278(1), 113–128 (1995)
Avramoff, A., Khan, W., Mizrahi, B., Domb, A.J.: Preparation and characterization of a novel once-daily formulation of diltiazem using arabinogalactan as a channeling agent. J. Appl. Polym. Sci. 126(S1), E197–E203 (2012)
Ehrenfreund-Kleinman, T., Azzam, T., Falk, R., Polacheck, I., Golenser, J., Domb, A.: Synthesis and characterization of novel water soluble amphotericin B-arabinogalactan conjugates. Biomaterials 23(5), 1327–1335 (2002)
Ehrenfreund-Kleinman, T., Gazit, Z., Gazit, D., Azzam, T., Golenser, J., Domb, A.: Synthesis and biodegradation of arabinogalactan sponges prepared by reductive amination. Biomaterials 23(23), 4621–4631 (2002)
Ehrenfreund-Kleinman, T., Golenser, J., Domb, A.J.: Conjugation of amino-containing drugs to polysaccharides by tosylation: amphotericin B-arabinogalactan conjugates. Biomaterials 25(15), 3049–3057 (2004)
Daniel-da-Silva, A.L., Ferreira, L., Gil, A.M., Trindade, T.: Synthesis and swelling behavior of temperature responsive κ-carrageenan nanogels. J. Colloid Interface Sci. 355(2), 512–517 (2011)
Keppeler, S., Ellis, A., Jacquier, J.: Cross-linked carrageenan beads for controlled release delivery systems. Carbohydr. Polym. 78(4), 973–977 (2009)
Sukhlaaied, W., Riyajan, S.-A.: Synthesis and properties of carrageenan grafted copolymer with poly (vinyl alcohol). Carbohydr. Polym. 98(1), 677–685 (2013)
Necas, J., Bartosikova, L.: Carrageenan: a review. Vet. Med. 58(4), 187–205 (2013)
Hezaveh, H., Muhamad, I.I.: Controlled drug release via minimization of burst release in pH-response kappa-carrageenan/polyvinyl alcohol hydrogels. Chem. Eng. Res. Des. 91(3), 508–519 (2013)
Kianfar, F., Antonijevic, M., Chowdhry, B., Boateng, J.S.: Lyophilized wafers comprising carrageenan and pluronic acid for buccal drug delivery using model soluble and insoluble drugs. Colloids Surf. B Biointerfaces 103, 99–106 (2013)
Kulkarni, R.V., Boppana, R., Krishna Mohan, G., Mutalik, S., Kalyane, N.V.: pH-responsive interpenetrating network hydrogel beads of poly (acrylamide)-carrageenan and sodium alginate for intestinal targeted drug delivery: synthesis, in vitro and in vivo evaluation. J. Colloid Interface Sci. 367(1), 509–517 (2012)
Leong, K.H., Chung, L.Y., Noordin, M.I., Mohamad, K., Nishikawa, M., Onuki, Y., Morishita, M., Takayama, K.: Carboxymethylation of kappa-carrageenan for intestinal-targeted delivery of bioactive macromolecules. Carbohydr. Polym. 83(4), 1507–1515 (2011)
Makino, K., Idenuma, R., Murakami, T., Ohshima, H.: Design of a rate-and time-programming drug release device using a hydrogel: pulsatile drug release from κ-carrageenan hydrogel device by surface erosion of the hydrogel. Colloids Surf. B Biointerfaces 20(4), 355–359 (2001)
Leong, K.H., Chung, L.Y., Noordin, M.I., Onuki, Y., Morishita, M., Takayama, K.: Lectin-functionalized carboxymethylated kappa-carrageenan microparticles for oral insulin delivery. Carbohydr. Polym. 86(2), 555–565 (2011)
Malafaya, P.B., Silva, G.A., Reis, R.L.: Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv. Drug Deliv. Rev. 59(4), 207–233 (2007)
Vaz, C.M., Van Doeveren, P., Reis, R., Cunha, A.: Development and design of double-layer co-injection moulded soy protein based drug delivery devices. Polymer 44(19), 5983–5992 (2003)
Vaz, C., Fossen, M., Van Tuil, R., De Graaf, L., Reis, R., Cunha, A.: Casein and soybean protein-based thermoplastics and composites as alternative biodegradable polymers for biomedical applications. J. Biomed. Mater. Res. Part A 65(1), 60–70 (2003)
Ruggiero, F., Exposito, J.-Y., Bournat, P., Gruber, V., Perret, S., Comte, J., Olagnier, B., Garrone, R., Theisen, M.: Triple helix assembly and processing of human collagen produced in transgenic tobacco plants. FEBS Lett. 469(1), 132–136 (2000)
Shoseyov O., Amitai H., Posen Y., Yaari A., Shilo S., Roth S., Dgany O., Tal T., Lapidot N.: Large-scale molecular farming of recombinant human collagen in transgenic tobacco (2010)
Kolattukudy P.E.: Polyesters in higher plants. In: Biopolyesters, pp. 1–49. Springer, New York (2001)
Dutta, P.K., Dutta, J., Tripathi, V.: Chitin and chitosan: chemistry, properties and applications. J. Sci. Ind. Res. 63(1), 20–31 (2004)
Rinaudo, M.: Chitin and chitosan: properties and applications. Prog. Polym. Sci. 31(7), 603–632 (2006)
de Alvarenga E.S.: Characterization and properties of chitosan. In: Biotechnology of Biopolymers, p. 91. (2011)
Bansal P., Verma S., Khan W., Kumar N.: Global patent and technological status of biodegradable polymers in drug delivery and tissue engineering. In: Biodegradable Polymers in Clinical Use and Clinical Development, pp. 665–725. Wiley, New York. doi:10.1002/9781118015810.ch18
Di Martino, A., Sittinger, M., Risbud, M.V.: Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 26(30), 5983–5990 (2005)
Malafaya, P., Pedro, A., Peterbauer, A., Gabriel, C., Redl, H., Reis, R.: Chitosan particles agglomerated scaffolds for cartilage and osteochondral tissue engineering approaches with adipose tissue derived stem cells. J. Mater. Sci. Mater. Med. 16(12), 1077–1085 (2005)
Necas, J., Bartosikova, L., Brauner, P., Kolar, J.: Hyaluronic acid (hyaluronan): a review. Vet. Med. 53(8), 397–411 (2008)
Burdick, J.A., Prestwich, G.D.: Hyaluronic acid hydrogels for biomedical applications. Adv. Mater. 23(12), H41–H56 (2011)
Sintov, A., Di-Capua, N., Rubinstein, A.: Cross-linked chondroitin sulphate: characterization for drug delivery purposes. Biomaterials 16(6), 473–478 (1995)
Chang, C.H., Liu, H.C., Lin, C.C., Chou, C.H., Lin, F.H.: Gelatin-chondroitin-hyaluronan tri-copolymer scaffold for cartilage tissue engineering. Biomaterials 24(26), 4853–4858 (2003)
Lee, C.H., Singla, A., Lee, Y.: Biomedical applications of collagen. Int. J. Pharm. 221(1), 1–22 (2001)
Khan W., Yadav D., Domb A.J., Kumar N.: Collagen. Biodegradable polymers in clinical use and clinical development: 59–89 (2011)
Gelse, K., Pöschl, E., Aigner, T.: Collagens—structure, function, and biosynthesis. Adv. Drug Deliv. Rev. 55(12), 1531–1546 (2003)
Neel, E.A.A., Bozec, L., Knowles, J.C., Syed, O., Mudera, V., Day, R., Hyun, J.K.: Collagen—emerging collagen based therapies hit the patient. Adv. Drug Deliv. Rev. 65(4), 429–456 (2013)
Brown, J., Timpl, R.: The collagen superfamily. Int. Arch. Allergy Immunol. 107(4), 484–490 (1995)
Friess, W.: Collagen–biomaterial for drug delivery. Eur. J. Pharm. Biopharm. 45(2), 113–136 (1998)
von der Mark, K.: Structure, biosynthesis and gene regulation of collagens in cartilage and bone, pp. 3–26. Academic Press, Orlando (1999)
Das, S., Khan, W., Mohsin, S., Kumar, N.: Miltefosine loaded albumin microparticles for treatment of visceral leishmaniasis: formulation development and in vitro evaluation. Polym. Adv. Technol. 22(1), 172–179 (2010). doi:10.1002/pat.1710
Ledward D., Phillips G., Williams P.: Gelatin. In: Handbook of Hydrocolloids, pp. 67–86. (2000)
Kratz, F.: Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J. Controlled Release 132(3), 171–183 (2008)
Elzoghby, A.O., Samy, W.M., Elgindy, N.A.: Albumin-based nanoparticles as potential controlled release drug delivery systems. J. Controlled Release 157(2), 168–182 (2012)
Domb A.J., Khan W.: Biodegradable polymers as drug carrier systems. In: Dumitriu S., Popa C. (eds) Polymeric Biomaterials, pp. 135–176. CRC Press, Boca Raton (2013)
Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., Notari, S., Ascenzi, P.: The extraordinary ligand binding properties of human serum albumin. IUBMB Life 57(12), 787–796 (2005)
Hu, Y.J., Liu, Y., Sun, T.Q., Bai, A.M., Lü, J.Q., Pi, Z.B.: Binding of anti-inflammatory drug cromolyn sodium to bovine serum albumin. Int. J. Biol. Macromol. 39(4), 280–285 (2006)
Roche, M., Rondeau, P., Singh, N.R., Tarnus, E., Bourdon, E.: The antioxidant properties of serum albumin. FEBS Lett. 582(13), 1783–1787 (2008)
Khan, W., Kumar, N.: Drug targeting to macrophages using paromomycin-loaded albumin microspheres for treatment of visceral leishmaniasis: an in vitro evaluation. J. Drug Target. 19(4), 239–250 (2011). doi:10.3109/1061186X.2010.492524
Haisch, A., Loch, A., David, J., Pruss, A., Hansen, R., Sittinger, M.: Preparation of a pure autologous biodegradable fibrin matrix for tissue engineering. Med. Biol. Eng. Comput. 38(6), 686–689 (2000)
Furst, W., Banerjee, A., Redl, H.: Comparison of structure, strength and cytocompatibility of a fibrin matrix supplemented either with tranexamic acid or aprotinin. J. Biomed. Mater. Res. B Appl. Biomater. 82(1), 109–114 (2007)
Han, D., Liu, W., Ao, Q., Wang, G.: Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix. Med. Hypotheses 71(3), 374–378 (2008)
Sathian, J., Sastry, T., Suguna, L., Lakshminarayana, Y., Radhakrishnan, G.: Fibrin as a matrix for grafting 2-hydroxyethyl methacrylate: Preparation and characterization of the graft and its in vivo evaluation for wound healing. J. Biomed. Mater. Res., Part A 65(4), 435–440 (2003)
Ryu, J.H., Kim, I.-K., Cho, S.-W., Cho, M.-C., Hwang, K.-K., Piao, H., Piao, S., Lim, S.H., Hong, Y.S., Choi, C.Y.: Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 26(3), 319–326 (2005)
Kumar, T., Vasantha Bai, M., Krishnan, L.K.: A freeze-dried fibrin disc as a biodegradable drug release matrix. Biologicals 32(1), 49–55 (2004)
Shim, G., Im, S., Lee, S., Park, J.Y., Kim, J., Jin, H., Lee, S., Im, I., Kim, D.-D., Kim, S.W.: Enhanced survival of transplanted human adipose-derived stem cells by co-delivery with liposomal apoptosome inhibitor in fibrin gel matrix. Eur. J. Pharm. Biopharm. 85(3), 673–681 (2013)
Jin, J., Hassanzadeh, P., Perotto, G., Sun, W., Brenckle, M.A., Kaplan, D., Omenetto, F.G., Rolandi, M.: A biomimetic composite from solution self-assembly of chitin nanofibers in a silk fibroin matrix. Adv. Mater. 25(32), 4482–4487 (2013)
Miroiu, F., Socol, G., Visan, A., Stefan, N., Craciun, D., Craciun, V., Dorcioman, G., Mihailescu, I., Sima, L., Petrescu, S.: Composite biocompatible hydroxyapatite–silk fibroin coatings for medical implants obtained by matrix assisted pulsed laser evaporation. Mater. Sci. Eng. B169(1), 151–158 (2010)
Wang, Y., Bella, E., Lee, C.S., Migliaresi, C., Pelcastre, L., Schwartz, Z., Boyan, B.D., Motta, A.: The synergistic effects of 3-D porous silk fibroin matrix scaffold properties and hydrodynamic environment in cartilage tissue regeneration. Biomaterials 31(17), 4672–4681 (2010)
Altman, A.M., Gupta, V., RÃos, C.N., Alt, E.U., Mathur, A.B.: Adhesion, migration and mechanics of human adipose-tissue-derived stem cells on silk fibroin-chitosan matrix. Acta Biomater. 6(4), 1388–1397 (2010)
Kasoju, N., Bora, U.: Silk fibroin based biomimetic artificial extracellular matrix for hepatic tissue engineering applications. Biomed. Mater. 7(4), 045004 (2012)
Liu, Y., Liu, H., Qian, J., Deng, J., Yu, T.: Regenerated silk fibroin membrane as immobilization matrix for peroxidase and fabrication of a sensor for hydrogen peroxide utilizing methylene blue as electron shuttle. Anal. Chim. Acta 316(1), 65–72 (1995)
Farag, Y., Leopold, C.S.: Development of shellac-coated sustained release pellet formulations. Eur. J. Pharm. Sci. 42(4), 400–405 (2011)
Limmatvapirat, S., Limmatvapirat, C., Puttipipatkhachorn, S., Nunthanid, J., Luangtana-anan, M., Sriamornsak, P.: Modulation of drug release kinetics of shellac-based matrix tablets by in-situ polymerization through annealing process. Eur. J. Pharm. Biopharm. 69(3), 1004–1013 (2008)
Soradech, S., Limatvapirat, S., Luangtana-anan, M.: Stability enhancement of shellac by formation of composite film: effect of gelatin and plasticizers. J. Food Eng. 116(2), 572–580 (2013)
Yu, C.-Y., Yin, B.-C., Zhang, W., Cheng, S.-X., Zhang, X.-Z., Zhuo, R.-X.: Composite microparticle drug delivery systems based on chitosan, alginate and pectin with improved pH-sensitive drug release property. Colloids Surf. B Biointerfaces 68(2), 245–249 (2009)
Hornig, S., Bunjes, H., Heinze, T.: Preparation and characterization of nanoparticles based on dextran–drug conjugates. J. Colloid Interface Sci. 338(1), 56–62 (2009)
Saboktakin, M.R., Tabatabaie, R., Maharramov, A., Ramazanov, M.A.: Synthesis and characterization of superparamagnetic chitosan–dextran sulfate hydrogels as nano carriers for colon-specific drug delivery. Carbohydr. Polym. 81(2), 372–376 (2010)
Shu, S., Zhang, X., Wu, Z., Wang, Z., Li, C.: Delivery of protein drugs using nanoparticles self-assembled from dextran sulfate and quaternized chitosan. J. Controlled Release 152, e170–e172 (2011)
Brondsted, H., Andersen, C., Hovgaard, L.: Crosslinked dextran—a new capsule material for colon targeting of drugs. J. Controlled Release 53(1), 7–13 (1998)
Cortesi, R., Esposito, E., Osti, M., Menegatti, E., Squarzoni, G., Spencer Davis, S., Nastruzzi, C.: Dextran cross-linked gelatin microspheres as a drug delivery system. Eur. J. Pharm. Biopharm. 47(2), 153–160 (1999)
Hovgaard, L., Brondsted, H.: Dextran hydrogels for colon-specific drug delivery. J. Controlled Release 36(1), 159–166 (1995)
Rehm, B.H.: Bacterial polymers: biosynthesis, modifications and applications. Nat. Rev. Microbiol. 8(8), 578–592 (2010)
Averous L., Pollet E.: Biodegradable polymers. In: Environmental Silicate Nano-Biocomposites, pp. 13–39. Springer, New York
Nair L.S., Laurencin C.T.: Polymers as biomaterials for tissue engineering and controlled drug delivery. In: Tissue Engineering I, pp. 47–90. Springer, New York (2006)
Ueda, H., Tabata, Y.: Polyhydroxyalkanonate derivatives in current clinical applications and trials. Adv. Drug Deliv. Rev. 55(4), 501–518 (2003)
Nair, L.S., Laurencin, C.T.: Biodegradable polymers as biomaterials. Prog. Polym. Sci. 32(8), 762–798 (2007)
Ashiuchi M., Misono H.: Poly γ glutamic Acid. Biopolymers Online (2002)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Doppalapudi, S., Katiyar, S., Domb, A.J., Khan, W. (2015). Biodegradable Natural Polymers. In: Puoci, F. (eds) Advanced Polymers in Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-12478-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-12478-0_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12477-3
Online ISBN: 978-3-319-12478-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)